# EDGAR Filing Document

**Accession Number:** 0001730574
**File Stem:** 0001730574-23-000003
**Filing Date:** 2023-3
**Character Count:** 28068
**Document Hash:** 6feec2b33da7c195c6bc813b9b5685b6
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001730574-23-000003.hdr.sgml**: 20230331

**ACCESSION NUMBER**: 0001730574-23-000003

**CONFORMED SUBMISSION TYPE**: SC 13D

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20230331

**DATE AS OF CHANGE**: 20230331

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Zura Bio Ltd
- **CENTRAL INDEX KEY:** 0001855644
- **STANDARD INDUSTRIAL CLASSIFICATION:** BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
- **IRS NUMBER:** 000000000
- **STATE OF INCORPORATION:** E9
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SC 13D
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-92696
- **FILM NUMBER:** 23783716

**BUSINESS ADDRESS:**
- **STREET 1:** 4225 EXECUTIVE SQUARE
- **STREET 2:** SUITE 600
- **CITY:** LA JOLLA
- **STATE:** CA
- **ZIP:** 92037
- **BUSINESS PHONE:** 858-247-0520

**MAIL ADDRESS:**
- **STREET 1:** 4225 EXECUTIVE SQUARE
- **STREET 2:** SUITE 600
- **CITY:** LA JOLLA
- **STATE:** CA
- **ZIP:** 92037

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** JATT Acquisition Corp
- **DATE OF NAME CHANGE:** 20210407
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Athanor Capital, LP
- **CENTRAL INDEX KEY:** 0001730574
- **IRS NUMBER:** 320520630
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SC 13D

**BUSINESS ADDRESS:**
- **STREET 1:** 142 WEST 57TH STREET
- **STREET 2:** 11TH FLOOR, SUITE 09-126
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10019
- **BUSINESS PHONE:** 646-813-2470

**MAIL ADDRESS:**
- **STREET 1:** 142 WEST 57TH STREET
- **STREET 2:** 11TH FLOOR, SUITE 09-126
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10019

```

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. )*

Zura Bio Limited

(Name of Issuer)

Class A Ordinary Shares, $0.0001 par value per share

(Title of Class of Securities)

G011FJXV49

(CUSIP Number)

Athanor Capital, L.P.142 W57th Street Suite 09-126, 11th Floor
 for Mail New York, NY 10019
Attn: Parvinder ThiaraTel: (646) 813-2470

(Name, Address and Telephone Number of Person Authorized to

Receive Notices and Communications)

March 20,2023

(Date of Event which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report
 the acquisition that is the subject of this Schedule 13D, and is filing this
 schedule because of Sections 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g),
 check the following box. [ _ ]
Note: Schedules filed in paper format shall include a signed original and
 five copies of the schedule, including all exhibits. See Section 240.13d-7
 for other parties to whom copies are to be sent.
* The remainder of this cover page shall be filled out for a reporting person's
 initial filing on this form with respect to the subject class of securities,
 and for any subsequent amendment containing information which would alter
 disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not
 be deemed to be "filed" for the purpose of Section 18 of the
 Securities Exchange Act of 1934 ("Act") or otherwise subject
 to the liabilities of that section of the Act but shall be
subject to all other provisions of the Act (however, see the Notes).

CUSIP No. G011FJXV49
13D
Page 2 of 14 Pages

1
NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS.
 OF ABOVE PERSONS (ENTITIES ONLY)

Athanor Capital, LP
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

(see instructions)
(a)
[ _ ]

(b)
[ _ ]

3
SEC USE ONLY

4
SOURCE OF FUNDS* (see instructions)

AF

5
CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED

PURSUANT TO ITEMS 2(d) OR 2(e)

[ _ ]

6
CITIZENSHIP OR PLACE OF ORGANIZATION

	Delaware

7
SOLE VOTING POWER
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH:

0

8
SHARED VOTING POWER

6,801,633 (1)

9
SOLE DISPOSITIVE POWER

0

10
SHARED DISPOSITIVE POWER

	6,801,633 (1)
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

6,801,633 (1)

12
CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*

(see instructions)

[ _ ]

13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

25.14% (2)

14
TYPE OF REPORTING PERSON* (see instructions)

PN, IA

(1) Consists of 4,757,742 Class A Ordinary Shares held by Athanor Master
 Fund, LP and 2,043,891 Class A Ordinary Shares held by Athanor International
 Master Fund, LP.
(2) Based on 27,050,000 Class A Ordinary Shares outstanding as reported in
 the Issuer's Registration Statement on Form S-4 filed with the
 Securities and Exchange Commission (the "SEC") on March 2, 2023.

CUSIP No. G011FJXV49
13D
Page 3 of 14 Pages

1
NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS.
 OF ABOVE PERSONS (ENTITIES ONLY)

Athanor Capital GP, LLC
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

(see instructions)
(a)
[ _ ]

(b)
[ _ ]

3
SEC USE ONLY

4
SOURCE OF FUNDS* (see instructions)

AF

5
CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED

PURSUANT TO ITEMS 2(d) OR 2(e)

[ _ ]

6
CITIZENSHIP OR PLACE OF ORGANIZATION

	Delaware

7
SOLE VOTING POWER
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH:

0

8
SHARED VOTING POWER

6,801,633 (1)

9
SOLE DISPOSITIVE POWER

0

10
SHARED DISPOSITIVE POWER

	6,801,633 (1)
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

6,801,633 (1)

12
CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*

(see instructions)

[ _ ]

13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

25.14% (2)

14
TYPE OF REPORTING PERSON* (see instructions)

OO

(1) Consists of 4,757,742 Class A Ordinary Shares held by Athanor Master
 Fund, LP and 2,043,891 Class A Ordinary Shares held by Athanor International
 Master Fund, LP.
(2) Based on 27,050,000 Class A Ordinary Shares outstanding as reported in
 the Issuer's Registration Statement on Form S-4 filed with the
 Securities and Exchange Commission (the "SEC") on March 2, 2023.

CUSIP No. G011FJXV49
13D
Page 4 of 14 Pages

1
NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF
 ABOVE PERSONS (ENTITIES ONLY)

Athanor Master Fund, LP
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

(see instructions)
(a)
[ _ ]

(b)
[ _ ]

3
SEC USE ONLY

4
SOURCE OF FUNDS* (see instructions)

WC

5
CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED

PURSUANT TO ITEMS 2(d) OR 2(e)

[ _ ]

6
CITIZENSHIP OR PLACE OF ORGANIZATION

	Delaware

7
SOLE VOTING POWER
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH:

0

8
SHARED VOTING POWER

4,757,742

9
SOLE DISPOSITIVE POWER

0

10
SHARED DISPOSITIVE POWER

	4,757,742
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

4,757,742

12
CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*

(see instructions)

[ _ ]

13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

17.59% (2)

14
TYPE OF REPORTING PERSON* (see instructions)

PN

(1) Consists of 4,757,742 Class A Ordinary Shares held by Athanor Master Fund,
 LP and 2,043,891 Class A Ordinary Shares held by Athanor
 International Master Fund, LP.

CUSIP No. G011FJXV49
13D
Page 5 of 14 Pages

1
NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS.
 OF ABOVE PERSONS (ENTITIES ONLY)

Athanor Master Fund, LP
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

(see instructions)
(a)
[ _ ]

(b)
[ _ ]

3
SEC USE ONLY

4
SOURCE OF FUNDS* (see instructions)

WC

5
CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED

PURSUANT TO ITEMS 2(d) OR 2(e)

[ _ ]

6
CITIZENSHIP OR PLACE OF ORGANIZATION

	Cayman Islands

7
SOLE VOTING POWER
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH:

0

8
SHARED VOTING POWER

4,757,742

9
SOLE DISPOSITIVE POWER

0

10
SHARED DISPOSITIVE POWER

	4,757,742
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

4,757,742

12
CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*

(see instructions)

[ _ ]

13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

17.59% (1)

14
TYPE OF REPORTING PERSON* (see instructions)

PN

(1) Consists of 4,757,742 Class A Ordinary Shares held by
 Athanor Master Fund, LP and 2,043,891 Class A Ordinary Shares
 held by Athanor International Master Fund, LP.

CUSIP No. G011FJXV49
13D
Page 6 of 14 Pages

1
NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS.
 OF ABOVE PERSONS (ENTITIES ONLY)

Athanor Capital Partners, LP
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

(see instructions)
(a)
[ _ ]

(b)
[ _ ]

3
SEC USE ONLY

4
SOURCE OF FUNDS* (see instructions)

AF

5
CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED

PURSUANT TO ITEMS 2(d) OR 2(e)

[ _ ]

6
CITIZENSHIP OR PLACE OF ORGANIZATION

	Delaware

7
SOLE VOTING POWER
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH:

0

8
SHARED VOTING POWER

4,757,742 (1)

9
SOLE DISPOSITIVE POWER

0

10
SHARED DISPOSITIVE POWER

	4,757,742 (1)
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

4,757,742 (1)

12
CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*

(see instructions)

[ _ ]

13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

17.59% (2)

14
TYPE OF REPORTING PERSON* (see instructions)

PN

(1) Shares held by Athanor Master Fund, LP.
(2) Based on 27,050,000 Class A Ordinary Shares outstanding as
 reported in the Issuer's Registration Statement on
 Form S-4 filed with theSecurities and Exchange
 Commission (the "SEC") on March 2, 2023.

CUSIP No. G011FJXV49
13D
Page 7 of 14 Pages

1
NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS.
 OF ABOVE PERSONS (ENTITIES ONLY)

Athanor International Master Fund, LP
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

(see instructions)
(a)
[ _ ]

(b)
[ _ ]

3
SEC USE ONLY

4
SOURCE OF FUNDS* (see instructions)

WC

5
CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED

PURSUANT TO ITEMS 2(d) OR 2(e)

[ _ ]

6
CITIZENSHIP OR PLACE OF ORGANIZATION

	Cayman Islands

7
SOLE VOTING POWER
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH:

0

8
SHARED VOTING POWER

2,043,891

9
SOLE DISPOSITIVE POWER

0

10
SHARED DISPOSITIVE POWER

	2,043,891
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

2,043,891

12
CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*

(see instructions)

[ _ ]

13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

7.56% (1)

14
TYPE OF REPORTING PERSON* (see instructions)

PN

(1) Based on 27,050,000 Class A Ordinary Shares outstanding as
reported in the Issuer's Registration Statement on Form S-4
filed with the Securities and Exchange Commission
 (the "SEC") on March 2, 2023.

CUSIP No. G011FJXV49
13D
Page 8 of 14 Pages

1
NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF
 ABOVE PERSONS (ENTITIES ONLY)

Athanor International Fund GP, LP
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

(see instructions)
(a)
[ _ ]

(b)
[ _ ]

3
SEC USE ONLY

4
SOURCE OF FUNDS* (see instructions)

AF

5
CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED

PURSUANT TO ITEMS 2(d) OR 2(e)

[ _ ]

6
CITIZENSHIP OR PLACE OF ORGANIZATION

	Delaware

7
SOLE VOTING POWER
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH:

0

8
SHARED VOTING POWER

2,043,891 (1)

9
SOLE DISPOSITIVE POWER

0

10
SHARED DISPOSITIVE POWER

	2,043,891 (1)
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

2,043,891

12
CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*

(see instructions)

[ _ ]

13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

7.56% (2)

14
TYPE OF REPORTING PERSON* (see instructions)

PN

(1) Shares held by Athanor International Master Fund, LP.
(2) Based on 27,050,000 Class A Ordinary Shares outstanding as
 reported in the Issuer's Registration Statement on Form S-4
filed with the Securities and Exchange Commission (the "SEC")
 on March 2, 2023.

CUSIP No. G011FJXV49
13D
Page 9 of 14 Pages

1
NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS.
OF ABOVE PERSONS (ENTITIES ONLY)

Pavinder Thiara
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

(see instructions)
(a)
[ _ ]

(b)
[ _ ]

3
SEC USE ONLY

4
SOURCE OF FUNDS* (see instructions)

AF

5
CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED

PURSUANT TO ITEMS 2(d) OR 2(e)

[ _ ]

6
CITIZENSHIP OR PLACE OF ORGANIZATION

	United States

7
SOLE VOTING POWER
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH:

0

8
SHARED VOTING POWER

6,801,633 (1)

9
SOLE DISPOSITIVE POWER

0

10
SHARED DISPOSITIVE POWER

	6,801,633 (1)
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

6,801,633 (1)

12
CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*

(see instructions)

[ _ ]

13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

25.14% (2)

14
TYPE OF REPORTING PERSON* (see instructions)

IN

(1) Consists of 4,757,742 Class A Ordinary Shares held by Athanor Master Fund,
 LP and 2,043,891 Class A Ordinary Shares held by Athanor International
 Master Fund, LP.
(2) Based on 27,050,000 Class A Ordinary Shares outstanding as reported
 in the Issuer's Registration Statement on Form S-4 filed with
the Securities and Exchange Commission (the "SEC") on March 2, 2023.

CUSIP No. G011FJXV49
13D
Page 10 of 14 Pages

Item 1. Security and Issuer.

This statement on Schedule 13D relates to the Class A Ordinary Shares
 (the "Class A Shares"), par value $0.0001 per share, of Zura Bio Ltd.,
 a company incorporated under the laws of England and Wales
(the "Issuer"). The address of the Issuer's principal executive
 office is 4225 Executive Square, Suite 600 La Jolla, CA, 92037.

Item 2. Identity and Background.

(a)
 This Schedule 13D is being filed by and on behalf of the following
 (each, a "Reporting Person" and collectively, the "Reporting Persons"):
(i) Athanor Capital, LP ("Athanor Capital")
(ii) Athanor Capital GP, LLC ("Athanor Capital GP")
(iii) Athanor Master Fund, LP (the "Master Fund")
(iv) Athanor Capital Partners, LP ("Master GP")
(v) Athanor International Master Fund, LP (the "International Master Fund",
and together with the Master Fund, the "Funds")
(vi) Athanor International Fund GP, LP ("International Master GP")
(vii)Parvinder Thiara
The Reporting Persons are making this single, joint filing and the
 agreement among the Reporting Persons to file jointly is
attached hereto as Exhibit A.

(b)
 The principal business address of each Reporting Person
 is c/o Athanor Capital, LP, 142 W 57th St. Suite 09-126, New York, NY 10019.

(c)
 The Funds are private investment partnerships, the principal business of
 which is to make investments. The principal business of Master GP
is to actas the general partner of the Master Fund. The principal business
of International Master GP is to act as the general partner of the
 International MasterFund. The principal business of Athanor Capital
is to act as the investment adviser to the Funds. The principal
business of Athanor Capital GP is to actas the general partner of
Athanor Capital. Parvinder Thiara is the managing member of
 (i) Athanor Capital GP, (ii) Athanor Capital Partners GP, LLC,the
 general partner of Master GP, and (iii) Athanor
International Fund Ultimate GP, LLC,
the general partner of International Master GP.

(d -e)
 During the last five years, no Reporting Person has (i) been convicted in any
 criminal

proceeding (excluding traffic violations or similar misdemeanors) or
(ii) been a party to a civil proceeding of a judicial or administrative
body of competent jurisdiction resulting in its being subject to a
judgment, decree or final order enjoining future violations of, or
prohibiting or mandating activities subject to, federal or state
securities laws or finding any violation with respect to such laws.

(f)
 Athanor Capital is a Delaware limited partnership. Athanor Capital GP is a
Delaware limited liability company. The Master Fund is a Cayman Islands limited
 partnership. Master GP is a Delaware limited partnership. The International
Master Fund is a Cayman Islands limited partnership. International Master GP
is a Delaware limited partnership. Parvinder Thiara
is a citizen of the United States.

Item 3. Source and Amount of Funds or Other Consideration.

The source of such funds was the working capital of the Funds.

Item 4. Purpose of Transaction.

The Funds own a passive ownership interest in JATT Ventures, L.P., the sponsor
of JATT Acquisition Corp which merged with Issuer. Except as set forth herein,
the Reporting Persons do not have any present plans or proposals that relate
to or would result in any of the transactions described in subparagraphs
(a) through (j) of Item 4 of Schedule 13D.

The Reporting Persons expect to evaluate their investment on an ongoing basis,
and as a result may at any time or from time to time determine, either alone or
 as part of a group, to (a) acquire additional securities of the Issuer,
through open market purchases, privately negotiated transactions or otherwise,
 (b) dispose of all or a portion of the securities of the Issuer that they own,
 in the open market, in privately negotiated transactions or otherwise, or (c)
take any other available course of action, which could involve one or more of
the types of transactions or have one or more of the results described
 in subparagraphs (a) through (j) of Item 4 of Schedule 13D. Any such
 acquisition or disposition or other transaction would be made in
 compliance with all applicable laws and regulations and any agreement
 or agreements that have been or may be entered into with the Issuer.
The Reporting Persons reserve the right to change their intention with
 respect to any or all of such matters at any time. In reaching any decision
 as to a course of action, as well as to the specific elements thereof, the
 Reporting Persons expect that they would take into consideration a variety
 of factors, including but not limited to the following: the Issuer's financial
 condition, strategic direction, business, prospects and
 anticipated future developments, conditions in the securities markets,
general economic and industry conditions and other factors, actions
taken by the Issuer's management and Board of Directors, the market
price of the Issuer's securities, and changes
 in law and regulatory matters.

Item 5. Interest in Securities of the Issuer.

(a -b)
 The information requested by these paragraphs is incorporated herein
 by reference to the information provided on the cover
pages to this Schedule 13D.

(c)
 Except as described in this statement on Schedule 13D, the Reporting
 Persons have not effected any transactions in the Class A Shares
 during the past sixty days.

(d)
 No other person has the right to receive or the power to direct
 the receipt of dividends from, or the proceeds from the sale of,
the securities of the Issuer reported herein.

(e)
 Not applicable.

Item 6. Contracts, Arrangements, Understandings or Relationships
 With Respect to Securities of the Issuer.

The reporting persons have entered into an agreement with the Issuer
 dated March 23, 2023 agreeing that 2,500,000 of the Class A Ordinary Shares
 shall be subject to restrictions on the
transfer thereof until March 21, 2024.

Item 7. Material to be Filed as Exhibits.

Exhibit A - Joint Filing Agreement Exhibit B - Agreement dated
as of March 23, 2023, by and between the Reporting Persons and
 the Issuer. See Exhibit B.

CUSIP No. G011FJXV49
13D
Page 13 of 14 Pages

SIGNATURE
	After reasonable inquiry and to the best of my knowledge
 and belief, I certify that the information set forth in this
statement is true, complete and correct.

Athanor Capital, LP

By: Athanor Capital GP, LLC, its general partner

By: /s/ Nicholas Fernandez
Name: Nicholas Fernandez
Title: Authorized Signatory

Athanor Capital GP, LLC

By: /s/ Nicholas Fernandez
Name: Nicholas Fernandez
Title: Authorized Signatory

Athanor Master Fund, LP

By: Athanor Capital Partners, LP, its general partner
By: Athanor Capital Partners GP, LLC, its general partner
By: /s/ Nicholas Fernandez
Name: Nicholas Fernandez
Title: Authorized Signatory

Athanor Capital Partners, LP

By: Athanor Capital Partners GP, LLC, its general partner
By: /s/ Nicholas Fernandez
Name: Nicholas Fernandez
Title: Authorized Signatory

Athanor International Master Fund, LP

By: Athanor International Fund GP, LP, its general partner
By: Athanor International Fund Ultimate GP, LLC, its general partner
By: /s/ Nicholas Fernandez
Name: Nicholas Fernandez
Title: Authorized Signatory

Athanor International Fund GP, LP

By: Athanor International Fund Ultimate GP, LLC, its general partner
By: /s/ Nicholas Fernandez
Name: Nicholas Fernandez
Title: Authorized Signatory

Parvinder Thiara
/s/ Parvinder Thiara
Pavinder Thiara, individually

CUSIP No. G011FJXV49
13D
Page 14 of 14 Pages

Exhibit A

Joint Filing Agreement
	The undersigned hereby agree that the statement on Schedule
 13D to which this Agreement is annexed as Exhibit A, and any
amendments thereto, is and will be filed on behalf of each of them
in accordance with the provisions of Rule 13d-1(k) under the
Securities Exchange Act of 1934, as amended.
Dated: March 29, 2023

Athanor Capital, LP

By: Athanor Capital GP, LLC, its general partner

By: /s/ Nicholas Fernandez
Name: Nicholas Fernandez
Title: Authorized Signatory

Athanor Capital GP, LLC

By: /s/ Nicholas Fernandez
Name: Nicholas Fernandez
Title: Authorized Signatory

Athanor Master Fund, LP

By: Athanor Capital Partners, LP, its general partner
By: Athanor Capital Partners GP, LLC, its general partner
By: /s/ Nicholas Fernandez
Name: Nicholas Fernandez
Title: Authorized Signatory

Athanor Capital Partners, LP

By: Athanor Capital Partners GP, LLC, its general partner
By: /s/ Nicholas Fernandez
Name: Nicholas Fernandez
Title: Authorized Signatory

Athanor International Master Fund, LP

By: Athanor International Fund GP, LP, its general partner
By: Athanor International Fund Ultimate GP, LLC, its general partner
By: /s/ Nicholas Fernandez
Name: Nicholas Fernandez
Title: Authorized Signatory

Athanor International Fund GP, LP

By: Athanor International Fund Ultimate GP, LLC, its general partner
By: /s/ Nicholas Fernandez
Name: Nicholas Fernandez
Title: Authorized Signatory

Parvinder Thiara
/s/ Parvinder Thiara
Pavinder Thiara, individually

```

### Attached PDF Documents

**Attachment 1:** `jetpacksideletter.pdf`

March 23, 2023

Zura Bio Limited (“Zura”) (f/k/a JATT Acquisition Corp)
4225 Executive Square, Suite 600
La Jolla, CA 92037

Re: Additional Agreements relating to Amended and Restated Forward Purchase Agreement

Gentlemen:

Reference is made to that certain Amended and Restated Forward Purchase Agreement dated January 27, 2022 (“Forward Purchase Agreement”) as amended pursuant to that certain Amendment No. 2 to Forward Purchase Agreement (“Amendment No. 2”) dated as of March 8, 2023, among JATT Acquisition Corp, a Cayman Islands exempted company (the “Company”), and Athanor Master Fund, LP (“AMF”) and Athanor International Master Fund, LP (“AIMF”) (AMF and AIMF are, collectively, the “Purchasers”). Capitalized terms used and not otherwise defined herein have the meanings assigned to them in the Agreement. The Company and the Purchasers are herein referred to as the “Parties.”

In consideration of the mutual promises contained in this letter agreement (this “Letter Agreement”), to induce the Parties to enter into the Letter Agreement and consummate the transactions contemplated thereby and for other good and valuable consideration, the receipt and adequacy of which are hereby acknowledged, the Parties hereto acknowledge and agree as follows:

1. The Parties hereby enter into this Letter Agreement for the sole purpose of amending the terms of Amendment No. 2.
2. Section 12 of Amendment No. 2 is hereby replaced in its entirety and amended to read as follows:

Lock-up; Transfer Restrictions. The Purchasers agree that the Forward Purchase Backstop Shares shall be subject to the same lock-up and transfer restrictions as provided in the FPA.

The Amendment Shares shall be subject to the same lock-up and transfer restrictions as provided in the FPA, except that, in all events, the Amendment Shares shall continue to be subject to such lock-up and transfer restrictions until midnight, New York City time, on March 20, 2024, regardless of whether such restrictions have ceased to apply to the other shares governed by the terms of the FPA (and notwithstanding any provisions of the FPA to the contrary).

3. Any term of this Letter Agreement may be amended, terminated or waived only with the written consent of the Parties.
4. This Letter Agreement is governed by the laws of the state of New York, regardless of the laws that might otherwise govern under applicable principles of choice of law.
5. This Letter Agreement may be executed in two or more counterparts, each of which will be deemed an original, but all of which together will constitute one and the same instrument. Counterparts may be delivered via facsimile, electronic mail (including pdf or any electronic signature complying with the U.S. federal ESIGN Act of 2000, Uniform Electronic Transactions Act or other applicable law) or other transmission method and any counterpart so delivered will be deemed to have been duly and validly delivered and be valid and effective for all purposes.

6. Each Party (a) hereby irrevocably and unconditionally submits to the personal jurisdiction of the federal or state courts located in New York for the purpose of any suit, action, or other proceeding arising out of or based upon this Letter Agreement; (b) will not commence any suit, action or other proceeding arising out of or based upon this Letter Agreement except in the federal or state courts located in New York; and (c) hereby waives, and will not assert, by way of motion, as a defense, or otherwise, in any such suit, action or proceeding, any claim that it is not subject to the personal jurisdiction of the federal or state courts located in New York, that its property is exempt or immune from attachment or execution, that the suit, action or proceeding is brought in an inconvenient forum, that the venue of the suit, action or proceeding is improper or that this Agreement, or the subject matter hereof and thereof may not be enforced in or by the federal or state courts located in New York.

EACH PARTY HEREBY WAIVES ITS RIGHTS TO A JURY TRIAL OF ANY CLAIM OR CAUSE OF ACTION BASED UPON OR ARISING OUT OF THIS LETTER AGREEMENT, THE OTHER TRANSACTION DOCUMENTS, THE SECURITIES OR THE SUBJECT MATTER HEREOF OR THEREOF. THE SCOPE OF THIS WAIVER IS INTENDED TO BE ALL-ENCOMPASSING OF ANY AND ALL DISPUTES THAT MAY BE FILED IN ANY COURT AND THAT RELATE TO THE SUBJECT MATTER OF THIS TRANSACTION, INCLUDING, WITHOUT LIMITATION, CONTRACT CLAIMS, TORT CLAIMS (INCLUDING NEGLIGENCE), BREACH OF DUTY CLAIMS, AND ALL OTHER COMMON LAW AND STATUTORY CLAIMS. THIS SECTION HAS BEEN FULLY DISCUSSED BY EACH OF THE PARTIES HERETO AND THESE PROVISIONS WILL NOT BE SUBJECT TO ANY EXCEPTIONS. EACH PARTY HERETO HEREBY FURTHER WARRANTS AND REPRESENTS THAT SUCH PARTY HAS REVIEWED THIS WAIVER WITH ITS LEGAL COUNSEL, AND THAT SUCH PARTY KNOWINGLY AND VOLUNTARILY WAIVES ITS JURY TRIAL RIGHTS FOLLOWING CONSULTATION WITH LEGAL COUNSEL.

[Signature page follows.]

2

Very truly yours,

ATHANOR MASTER FUND, LP

By: Athanor Capital Partners, LP, its general partner
By: Athanor Capital Partners GP, LLC, its general partner

By: __________
Name: Parvinder Thiara
Title: Authorized Signatory

ATHANOR INTERNATIONAL MASTER FUND, LP

By: Athanor International Fund GP, its general partner
By: Athanor International Fund Ultimate GP, LLC, its general partner

By: __________
Name: Parvinder Thiara
Title: Authorized Signatory

Address for Notices: Athanor Capital,
LP parvinder.thiara@athanorcapital.com
and Nicholas.fernandez@athanorcapital.com

AGREED TO AND ACCEPTED BY:

ZURA BIO LIMITED

By: __________
Name: Someit Sidhu
Title: Chief Executive Officer

[Signature Page to Letter Agreement]